Detalhe da pesquisa
1.
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Nature
; 529(7586): 413-417, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26735014
2.
Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity.
Nature
; 514(7520): 54-8, 2014 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25079331
3.
Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments.
Nat Cell Biol
; 21(7): 879-888, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263265
4.
Author Correction: Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments.
Nat Cell Biol
; 26(5): 841, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443568
5.
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes.
Cancer Res
; 76(22): 6495-6506, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27671678
6.
Tumorigenesis: it takes a village.
Nat Rev Cancer
; 15(8): 473-83, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26156638
7.
Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer.
Cancer Res
; 75(20): 4407-15, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26359455
8.
Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer.
Cell Rep
; 11(10): 1549-63, 2015 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26051943